PSTM 2019 Abstract Supplement Posters code; 1,389 repeat code; 452 paralysis secondary to another cause) and 906 met inclusion criteria. For follow-up visits, 437 had zero and 771 had ≤3. Average age was 48 ± 20 years at diagnosis with the majority white (673) and non-Hispanic (835). Incidence increased with age: 461 subjects ≥50 years old. There was no difference in age or disease laterality. Most subjects presented to an emergency department (545). Per documentation, 550 subjects were stated to have complete facial paralysis but lacked documentation of total involvement. Forehead, eyelid, and mouth paralysis were most commonly noted. Changes in taste, sensation, or tearing were the most frequent associated symptoms. Treatment was generally steroid alone (444) or steroid plus antiviral (302). There were 174 complete resolutions, and 523 subjects had partial improvement in paralysis. The remaining subjects were lost to follow-up, or documentation regarding progress was terminated without clear resolution. For those patients who showed improvement in symptoms or complete resolution, 90% occurred by 107 ± 100 days. Dyskinesis was noted in 4 subjects and synkinesis in 2.
CONCLUSIONS:
The high rate of non-follow-up and poor documentation make the natural history of BP difficult to fully elucidate. Nevertheless, it seems safe to begin intervention-with reasonable assurance of disease plateau-at 200 days postdiagnosis. Additionally, BP sequela seem either inconsistently recorded or improperly detected and consequently undertreated. Minnesota, 1968 -1982 . Ann Neurol. 1986 20:622-627 
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METHODS:
A retrospective chart review of all VHRs between January 2009 and June 2017 at a single institution was performed. Demographic data, comorbidities, procedure details, length of stay (LOS), postoperative complications, and recurrence rates were recorded. Patients with <6 months follow-up or <30 cm 2 defect size were excluded. Follow-up was defined as surgical follow-up, abdominal computed tomography or magnetic resonance imaging, or surgical visits with well-documented abdominal examinations.
RESULTS:
A total of 185 patients were identified: group I (n = 42) received VHR + CS and group II (n = 143) received VHR alone. Differences in defect size (217.4 versus 149.2 cm 2 ; P = 0.02) and concurrent procedures (1.4 versus 0.9; P = 0.02) between groups I and II, respectively, reached significance. In addition, group I had significantly increased LOS (group I 15.0 days versus group II 4.6 days; P = 0.0049); however, no difference in postoperative complications (22.7% versus 21.6%; P = 0.89) or recurrence rates (22.7% versus 14.1%; P = 0.052) between groups I and II, respectively, was appreciated. Group I (n = 42), who received VHR + CS, was further stratified by specialty; group IA (n = 24) VHR + CS was performed by plastic surgeons, and group IB (n = 18) VHR + CS was performed by general surgeons. Differences in defect size (262.8 versus 149.6 cm 2 ; P = 0.046) and concurrent procedures (1.7 versus 0.9; P = 0.047) were noted in groups IA and IB, respectively. There were no differences in recurrence rate (20% versus 20%; P = 0.656), LOS (8.8 versus 6.3 days; P = 0.33), or complication rate (29.1% versus 27.8%; P = 0.6) in groups IA and IB, respectively.
CONCLUSION:
Despite the use of CS in larger, more complex VHRs in our overall patient population, VHR + CS provides comparable outcomes in abdominal wall reconstruction at our institution. In our subgroup analysis, VHR + CS performed by plastic surgeons showed no difference in LOS, complication rates, and recurrence rates compared to general surgeons, despite larger defect sizes, more concurrent procedures, and more complex reconstructions performed in the plastic surgery cohort. Performance of VHR + CS is a viable approach to improving overall outcomes in patients with larger, complex hernias and may directly benefit from plastic surgery participation.
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